Cannabis Rescheduling: Progress for the Industry, But Let’s Be Honest About Who Benefits
Unless you have been under a rock lately, or maybe on a different timeline than mine, you’ve probably heard the news that our current President will be signing an executive order to reschedule cannabis. A move from schedule 1 to 3 is a move that will help the industry, especially retail operators.
The news that cannabis is moving toward rescheduling has been framed as a major win—and in some ways, it is. But like most shifts in cannabis policy, the benefits won’t be felt evenly across the board.
For large, multi-state operators, rescheduling is a clear step forward. It opens doors to tax relief, banking relationships, and fewer operational hurdles. In short, it makes it easier for big companies to do business—and to do it more profitably.For small cannabis businesses, especially those already operating legally, rescheduling could offer some relief as well. Reduced tax burdens and clearer federal positioning may help stabilize margins and attract more cautious investors.
That matters.Now, for the average consumer, this change won’t feel revolutionary at all. Prices aren’t suddenly dropping. Access isn’t expanding overnight. And for communities that have historically borne the brunt of cannabis criminalization, rescheduling alone doesn’t address the deeper inequities that are already baked into the system.
This moment feels less like transformation and more like repositioning. As the conversation continues, it’s important to ask not just whether cannabis is being rescheduled, but who that rescheduling is really designed to serve—and what still needs to happen for meaningful progress to reach beyond boardrooms and balance sheets.
We’ll be watching closely. As always, CashColorCannabis remains focused on what these shifts mean in real terms—for operators, consumers, and the culture at large.
